Suppr超能文献

基于微小RNA的宫颈病变和癌症指纹图谱分析

MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer.

作者信息

Pisarska Justyna, Baldy-Chudzik Katarzyna

机构信息

Department of Microbiology and Molecular Biology, Collegium Medicum, University of Zielona Gora, 65-561 Zielona Gora, Poland.

出版信息

J Clin Med. 2020 Nov 15;9(11):3668. doi: 10.3390/jcm9113668.

Abstract

The regulatory functions of microRNA (miRNA) are involved in all processes contributing to carcinogenesis and response to viral infections. Cervical cancer in most cases is caused by the persistence of high-risk human papillomavirus (HR-HPV) infection. While oncogenic human papillomaviruses induce aberrant expression of many cellular miRNAs, this dysregulation could be harnessed as a marker in early diagnosis of HR-HPV infection, cervical squamous intraepithelial lesions, and cancer. In recent years, growing data indicate that miRNAs show specific patterns at various stages of cervical pathology. The aim of this review is to systematize current reports on miRNA capacity that can be utilized in personalized diagnostics of cervical precancerous and cancerous lesions. The analysis of the resources available in online databases (National Center for Biotechnology Information-NCBI, PubMed, ScienceDirect, Scopus) was performed. To date, no standardized diagnostic algorithm using the miRNA pattern in cervical pathology has been defined. However, the high sensitivity and specificity of the reported assays gives hope for the development of non-invasive diagnostic tests that take into account the heterogeneity of tumor-related changes. Due to this variability resulting in difficult to predict clinical outcomes, precise molecular tools are needed to improve the diagnostic and therapeutic process.

摘要

微小RNA(miRNA)的调控功能参与了所有导致癌症发生和对病毒感染反应的过程。大多数情况下,宫颈癌是由高危型人乳头瘤病毒(HR-HPV)持续感染引起的。虽然致癌性人乳头瘤病毒会诱导许多细胞miRNA的异常表达,但这种失调可作为HR-HPV感染、宫颈鳞状上皮内病变和癌症早期诊断的标志物。近年来,越来越多的数据表明,miRNA在宫颈病理的各个阶段呈现出特定模式。本综述的目的是对目前有关miRNA能力的报告进行系统化整理,这些能力可用于宫颈癌前病变和癌性病变的个性化诊断。我们对在线数据库(美国国立生物技术信息中心-NCBI、PubMed、ScienceDirect、Scopus)中的可用资源进行了分析。迄今为止,尚未定义在宫颈病理中使用miRNA模式的标准化诊断算法。然而,所报道检测方法的高灵敏度和特异性为开发考虑肿瘤相关变化异质性的非侵入性诊断测试带来了希望。由于这种变异性导致难以预测临床结果,因此需要精确的分子工具来改善诊断和治疗过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/7698009/523665769faf/jcm-09-03668-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验